CIRCUS: No Cyclosporine Benefit in STEMI PCI Setting CIRCUS: No Cyclosporine Benefit in STEMI PCI Setting

Hopeful that cyclosporine could limit myocardial reperfusion injury, as shown in small studies and animal models, CIRCUS investigators failed to show an improvement in hard clinical outcomes following PCI for STEMI. Heartwire from Medscape

Source: Medscape Cardiology Headlines - August 30, 2015 Category: Cardiology Tags: Cardiology News Source Type: news